Overview

Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa

Status:
Completed
Trial end date:
2002-09-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Determine the safety of isotretinoin in patients with recessive dystrophic epidermolysis bullosa.
Phase:
Phase 1
Details
Lead Sponsor:
University of North Carolina
Treatments:
Isotretinoin